1000例机器人妇科手术围术期并发症及影响因素分析
恶性肿瘤患者术中、术后并发症发生率均显著高于良性疾病患者,年龄≥40岁、BMI≥25 kg/m2、既往盆腹腔手术史、恶性肿瘤及合并慢性疾病是术后并发症的独立影响因素。
要点
- 机器人妇科手术术后并发症以下肢静脉血栓最多见(66例),术中并发症以血管和输尿管损伤为主。
- 恶性肿瘤患者术中并发症3.1%、术后并发症15.2%,均显著高于良性疾病患者。
- 年龄≥40岁、BMI≥25 kg/m2、既往盆腹腔手术史、恶性肿瘤、合并慢性疾病为术后并发症独立影响因素。
核心结论
- 机器人系统妇科手术并发症发生率因疾病种类和术式不同而异。
- 患者年龄≥40岁、BMI≥25 kg/m2、既往盆腹腔手术史、恶性肿瘤及合并慢性疾病是术后并发症的独立影响因素。
研究设计与样本
- 患者平均年龄(50.2±10.4)岁,平均BMI(24.4±3.6)kg/m2。
主要发现
- 术中并发症发生率恶性肿瘤3.1%(25/811)显著高于良性疾病0/189(χ²=4.778,P=0.029)。
- 子宫颈癌4.2%(17/405)、卵巢癌3.6%(4/112)术中并发症均显著高于子宫内膜癌1.4%(4/279)、外阴癌0/15(P均<0.05)。
- 术后并发症发生率恶性肿瘤15.2%(123/811)显著高于良性疾病3.7%(7/189;χ²=17.807,P<0.01),各恶性肿瘤间无显著差异(χ²=4.318,P=0.229)。
关键数值与推荐
- 单因素分析:年龄、BMI、既往盆腹腔手术史、疾病性质(良、恶性)、手术时间、合并慢性疾病(高血压、冠心病、糖尿病)对术后并发症发生有显著影响(P<0.05)。
- 多因素logistic回归:年龄≥40岁、BMI≥25 kg/m2、既往盆腹腔手术史、恶性肿瘤、合并慢性疾病是术后并发症的独立影响因素(P<0.05)。
临床怎么用
- 术前应评估患者年龄、BMI、盆腹腔手术史及合并慢性疾病,识别术后并发症高危人群。
- 对恶性肿瘤患者及合并上述危险因素者加强围术期监测,重点防范下肢静脉血栓等术后并发症。
局限性
- 本研究为单中心回顾性分析,结果外推需谨慎。
- 原文未报告并发症的具体防治干预措施及其效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the occurrence and influencing factors of perioperative complications after robotic gynecologic surgery. Methods: The clinical data and occurrence of perioperative complications in 1 000 cases robotic surgery completed in the First Affiliated Hospital of Zhengzhou University were retrospectively analyzed. Results: (1) Clinical data: the average age of the patients was (50.2±10.4) years old, and the average body mass index (BMI) was (24.4±3.6) kg/m2. Among 1 000 cases, 811 cases of them were malignant tumors, including 405 cases of cervical cancer, 279 cases of endometrial carcinoma, 112 cases of epithelial ovarian cancer (EOC), 15 cases of vulvar cancer; 189 cases of them were benign diseases, including 43 cases of uterine prolapse, 57 cases hysterectomy of uterine leiomyoma and adenomyosis of the uterus ≥12 weeks, 84 cases myomectomy of uterine leiomyoma, and 5 cases of fallopian tubal ligation requiring anastomosis. Surgical methods: in patients with malignant tumors, cervical cancer, hysterectomy plus salpingectomy or salpingo-oophorectomy for stage Ⅰa1, and radical hysterectomy plus pelvic lymphatic dissection plus salpingectomy or salpingo-oophorectomy for stage Ⅰa2-Ⅱb. Endometrial carcinoma, performed by staging surgery. Staging surgery for EOC with early stage and cytoreductive surgery with advanced EOC. Vulvar cancer, extensive vulvar resection plus inguinal lymphadenectomy. In patients with benign diseases, uterine prolapse, hysterectomy plus salpingectomy or salpingo-oophorectomy plus sacrocolpopexy. Uterine leiomyoma or adenomyosis with uterus ≥ 12 weeks, hysterectomy plus salpingectomy or salpingo-oophorectomy. Myomectomy for patients requiring uterine preservation with uterine leiomyoma. Tubal anastomosis for patients with fallopian tubal ligation. (2) Surgical complications: intraoperative complications occurred in 25 patients (2.5%, 25/1 000), including 11 patients with vascular laceration, 11 patients with ureteral injury, 2 patients with bladder injury, and 1 patient with intestinal injury. Postoperative complications occurred in 130 patients (13.0%, 130/1 000), including 66 cases of lower limb venous thrombosis, 20 cases of lymphatic cyst, 8 cases of hydronephrosis, 9 cases of ileus, 16 cases with infection, 6 cases with genital fistula, 4 cases with trocar site herniation and 1 case with subcutaneous emphysema. The incidence of intraoperative complications was 3.1% (25/811) in malignant tumors and no case in benign diseases, the incidence rate in malignant tumors was significantly higher than that in benign diseases (χ²=4.778, P=0.029). The incidence rate in cervical cancer (4.2%, 17/405) and EOC (3.6%, 4/112) were significantly higher than those in endometrial carcinoma (1.4%, 4/279) and vulvar cancer (0/15; P<0.05). The incidence of postoperative complications was 15.2% (123/811) in malignant tumors and 3.7% (7/189) in benign diseases. The incidence rate in malignant tumors was significantly higher than that in benign diseases (χ²=17.807, P<0.01), but there were no significant difference among different malignant tumors (χ²=4.318, P=0.229). (3) The correlative factors affecting the occurrence of surgical complications: patient's age, BMI, previous pelvic or abdominal surgery history, the nature of disease (malignant or benign), operation time, and comorbidities had a significant impact on the incidence of postoperative complications (P<0.05). Multivariate logistic regression analysis showed that the patient's age ≥40 years old, BMI ≥25 kg/m2, previous pelvic or abdominal surgery history, malignant tumors and comorbidities were independent influential factors of the postoperative complications (P<0.05). Conclusions: Perioperative complications vary according to the type of the surgery. The age, BMI, previous pelvic or abdominal surgery history, malignant tumors, and comorbidities are influential factors of postoperative complications. 目的: 探讨机器人系统妇科手术的手术并发症发生情况,并分析其影响因素。 方法: 收集2014年10月至2019年6月郑州大学第一附属医院完成的1 000例机器人系统妇科手术患者的临床资料,回顾性分析其手术并发症发生情况,并对影响手术并发症发生的相关因素进行分析。 结果: (1)临床资料:1 000例机器人系统妇科手术患者的年龄为(50.2±10.4)岁,体质指数(BMI)为(24.4±3.6)kg/m2。其中,恶性肿瘤811例,包括子宫颈癌405例、子宫内膜癌279例、卵巢上皮性癌(卵巢癌)112例、外阴癌15例;良性疾病189例,包括子宫脱垂43例、子宫≥孕12周的子宫肌瘤及子宫腺肌病57例、要求保留子宫的子宫肌瘤84例、要求复通的输卵管结扎患者5例。手术方式:恶性肿瘤患者中,子宫颈癌Ⅰa1期患者行筋膜外子宫全切除+双侧输卵管(或附件)切除术,Ⅰa2~Ⅱb期患者行子宫广泛性切除+双侧输卵管(或附件)切除+盆腔淋巴清扫术;子宫内膜癌患者行子宫内膜癌全面分期手术;卵巢癌早期患者行全面分期手术,晚期患者行肿瘤细胞减灭术;外阴癌行外阴广泛性切除+腹股沟淋巴清扫术。良性疾病患者中,子宫脱垂患者行子宫全切除+双侧输卵管(或附件)切除+阴道骶骨固定术;子宫肌瘤、子宫腺肌病等子宫≥孕12周患者行子宫全切除+双侧输卵管(或附件)切除术;子宫肌瘤要求保留子宫的患者行子宫肌瘤剔除术;输卵管结扎要求复通的患者行输卵管复通术。(2)手术并发症:1 000例机器人系统妇科手术患者中,25例(2.5%,25/1 000)患者出现术中并发症,其中血管损伤11例、输尿管损伤11例、膀胱损伤2例、肠管损伤1例;130例(13.0%,130/1 000)患者出现术后并发症,其中下肢静脉血栓66例、淋巴潴留囊肿20例、感染16例、肠梗阻9例、肾积水8例、生殖道瘘6例、腹壁切口疝4例、皮下气肿1例。术中并发症的发生率,恶性肿瘤患者为3.1%(25/811),显著高于良性疾病患者(0/189;χ²=4.778;P=0.029);子宫颈癌(4.2%,17/405)、卵巢癌(3.6%,4/112)均显著高于子宫内膜癌(1.4%,4/279)、外阴癌(0/15;P均<0.05)。术后并发症的发生率,恶性肿瘤患者为15.2%(123/811),显著高于良性疾病患者[3.7%(7/189);χ²=17.807,P<0.01],但各恶性肿瘤间比较无显著差异(χ²=4.318,P=0.229)。(3)影响术后并发症发生的相关因素:单因素分析显示,患者的年龄、BMI、既往盆腹腔手术史、疾病性质(良、恶性)、手术时间、有无合并慢性疾病(包括高血压、冠心病、糖尿病)对术后并发症的发生有显著影响(P<0.05);多因素logistic回归法分析显示,患者的年龄≥40岁、BMI≥25 kg/m2、既往有盆腹腔手术史、恶性肿瘤、合并慢性疾病是影响术后并发症发生的独立因素(P<0.05)。 结论: 机器人系统妇科手术的手术并发症发生率因不同疾病的不同术式而异,患者的年龄、BMI、既往盆腹腔手术史、恶性肿瘤及合并慢性疾病对术后并发症的发生有显著影响。.
引用
- Huang XT, Ji M, Zhao Z, et al. [Analysis of perioperative complications and influencing factors of complications in 1 000 cases of robotic gynecological surgery]. Zhonghua Fu Chan Ke Za Zhi. 2021. PMID: 34034421. doi:10.3760/cma.j.cn112141-20201217-00896
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。